MYF-01-37

CAS No. 2416417-65-5

MYF-01-37( 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one )

Catalog No. M24113 CAS No. 2416417-65-5

MYF-01-37 is a novel covalent TEAD inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 58 In Stock
2MG 32 In Stock
5MG 52 In Stock
10MG 92 In Stock
25MG 169 In Stock
50MG 291 In Stock
100MG 435 In Stock
200MG Get Quote In Stock
500MG 918 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MYF-01-37
  • Note
    Research use only, not for human use.
  • Brief Description
    MYF-01-37 is a novel covalent TEAD inhibitor.
  • Description
    MYF-01-37 is a novel covalent TEAD inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TEAD
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2416417-65-5
  • Formula Weight
    298.3
  • Molecular Formula
    C15H17F3N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (838.08 mM)
  • SMILES
    CC(CC1)(CN1C(C=C)=O)Nc1cccc(C(F)(F)F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kurppa K J , Liu Y , To C , et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway[J]. Cancer Cell, 2020, 37(1):104-122.e12.
molnova catalog
related products
  • KIRA6

    KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade.

  • PLpro inhibitor

    PLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM).

  • BDS I

    Potent and reversible Kv3.4 potassium channel blocker (IC50 = 47 nM); also attenuates inactivation of sodium currents by acting on Nav1.7 and Nav1.3 channels. Enhances TTX-sensitive sodium currents in rat small dorsal root ganglion neurons. Neuroprotective.